SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Epileptiform activity in Dravet syndrome, caused by impaired expression of the SCN1A gene (alpha subunit of sodium channel protein type 1), can be stopped with high efficiency by stiripentol.